Observational studyJournal of advanced nursing2025
WHO ICOPE Programme Adherence of 8672 Older Age People Over 2-Years of Follow-Up.
Observational study in Journal of advanced nursing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Identification of pre-frail/frail older adults using the Integrated Care for Older People WHO Step1 screening tool: a cross sectional study.International journal of nursing studies advances · 2026Article
- Developing Customized Personas to Capture Intrinsic Capacity Profiles and Digital Monitoring Intentions in Older Adults: Mixed Methods Study.JMIR aging · 2026Article
- Advancing healthy ageing in Greece: the WHO ICOPE protocol within the JA PreventNCD framework.BMC geriatrics · 2026Article
- Insights on geroscience pre-clinical and clinical trials to promote healthy aging from the Intrinsic Capacity, Frailty and Sarcopenia Research Task Force 2025.The Journal of frailty & aging · 2026Review
- Development and Feasibility Assessment of an Intrinsic Capacity Program in Primary Care: Protocol for an Implementation Science Approach.JMIR research protocols · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
aimTo compare the characteristics of participants who discontinued prematurely with those who remained in the ICOPE program (Integrated Care for Older PEople) in France and to compare completely adherent participants with partially adherent ones after 2 years of follow-up.
designRetrospective observational study.
methodsWe analysed the data of older age people participating during 2 years from the ICOPE MONITOR database. The study compared the population that discontinued follow-up with the population currently in follow-up. Among the population in follow-up, a comparison was made between the completely adherent and partially adherent populations.
resultsIn total, 8672 participants had a follow-up period of at least 2 years. After 2 years, three-quarters of the participants were still in follow-up with varying levels of adherence. Participants who discontinued follow-up are older and had more compromised Step 1 levels across all domains of intrinsic capacity (IC). Partially adherent participants were older and generally more compromised in IC than completely adherent participants. Those participants least adherent to ICOPE presented higher declines in clinical parameters.
conclusionAmong autonomous older age people, the most impaired in intrinsic capacity domains and aged participants were more likely to discontinue follow-up, highlighting the need to focus efforts on this group. On the other hand, younger robust and healthier older age people represent a good target for ICOPE program, in terms of adherence and primary prevention. REPORTED
methodEQUATOR guidelines: STROBE. PATIENT OF PUBLIC CONTRIBUTION: No patient or public contribution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.